This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Disease Modelling 2023
May 03-04, 2023
2-Day Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu
Key Sessions
Clare Jones
Modelling Alzheimer’s Disease using Induced-Pluripotent Stem Cells (IPSCs)
Talisman Therapeutics, UK
Robert Vries
Patient-derived organoid as a clinically relevant model for human disease modelling
Hubrecht Organoid Technology, Netherlands
keyboard_arrow_right

Disease Modelling - Day 1 - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search
Disease Modelling - Day 1 - EST/EDT (Eastern Daylight, GMT-4)
search
Showing 1 of 1 Streams
08:00 - 08:05
Welcoming Remarks
08:05 - 08:35
Modelling Alzheimer’s Disease using Induced-Pluripotent Stem Cells (IPSCs)
08:35 - 08:45
Break & Networking
08:45 - 09:15
A Rare Neurodevelopmental Disorder: HNRNPH2
  • Casey McPherson - Founder and President, To Cure A Rose Foundation, USA
  • Rodney A. Bowling Jr. - Chief Scientific Officer, Everlum Bio, USA
09:15 - 09:45
A Clinical Trial: Treatment for Von Hippel-Lindau (VHL) Disease
  • Othon Iliopoulos, MD, PhD - Associate Professor of Medicine, Massachusetts General Hospital Cancer Center, Harvard University Medical Center, USA
  • Joshua Mann, MPH - Director of Health, VHL Alliance, USA
09:45 - 10:15
Patient-derived organoid as a clinically relevant model for human disease modelling
10:15 - 10:20
End of Day / Networking on the Platform
NextDisease Modelling - Day 2
Filter
Topics
Choose Day